جستجوی استاد راهنمای دانشگاهی

• Radiation Biology
• Radiation Carcinogenesis
• Radiation Applications in Medicine
• +۳ مورد دیگر

John Ford is an Associate Professor in the Department of Nuclear Engineering at Texas A&M University. His research focuses on radiobiology, radiation carcinogenesis, and medical applications of radiation. He holds academic appointments within the College of Engineering and contributes to the Health Physics, Radiation Biology & Medical Physics research group. Education includes a B.S. and M.S. in Nuclear Engineering from Mississippi State University (1982, 1986), a Ph.D. in Biomedical Sciences from the University of Tennessee (1992), and postdoctoral training at Oak Ridge National Laboratory (1992–1993). His work emphasizes understanding radiation effects on biological systems, with notable contributions to radiation dosimetry, bystander signaling mechanisms, and dietary modulation of radiation damage. Recent studies explore space radiation monitoring technologies and therapeutic applications of radiation. Awards include the BP Award for Teaching Excellence (2007) and ARRO Educator of the Year (2013–2014). Research spans interdisciplinary areas such as radiation-induced cancer mechanisms, nutritional interventions to mitigate radiation effects, and advanced radiation detection instrumentation. He has advised numerous projects in radiation safety curriculum development and collaborated on NASA-funded studies modeling radiation impacts on astronauts.

• Immunology
• Virology
• Inflammation
• +۵ مورد دیگر

Santiago F. González is a Group Leader at the Institute for Research in Biomedicine (IRB) in Bellinzona, Switzerland, and an extraordinary professor at the University of Italian Switzerland (USI). He earned dual PhDs in microbiology (University of Santiago de Compostela, Spain) and immunology (University of Copenhagen, Denmark), followed by postdoctoral work (2007–2011) at Harvard Medical School's Immune Disease Institute under Michael Carroll. PhD in Microbiology, University of Santiago de Compostela PhD in Immunology, University of Copenhagen His research focuses on immune system dynamics during respiratory viral infections, vaccination, and cancer metastasis. Key areas include influenza recognition , lymph node inflammation , and immune cell behavior in vivo. He pioneered studies on C-type lectin receptors (e.g., SIGN-R1) in viral immunity and epigenetic modulators for inflammation. Recent publications highlight his work in epigenetic drug development , nanovaccines , and computational tools for immune cell tracking. His group uses two-photon intravital microscopy and spatial-temporal modeling to dissect immune responses. Scientific awards include three EU Marie Curie Fellowships (2004–2013), enabling his transition to independent research. His collaborations span Harvard, USI, and European institutions, with grants from the EU and Swiss research bodies. His lab at IRB, established via the 2013 Marie Curie Career Integration Grant , develops novel imaging approaches and therapeutic strategies for infectious and immune-mediated diseases.

• Molecular Imaging
• Biomedical Imaging
• Optical Coherence Tomography
• +۳ مورد دیگر

Adam de la Zerda is an Associate Professor at Stanford University's Department of Structural Biology (School of Medicine) and Electrical Engineering (by courtesy). He develops advanced optical molecular imaging technologies combining nanoparticle contrast agents and adaptive OCT systems for cancer and ophthalmic disease research. Technion-Israel Institute of Technology (BSc, 2005) Stanford University (PhD, 2011) UC Berkeley (Postdoctoral Fellowship) Research Themes : Virtual biopsy using machine learning-enhanced OCT Gold nanorod-based molecular contrast agents Speckle noise reduction for cellular resolution Needle beam optical coherence tomography angiography His 15 most recent publications demonstrate technical innovations in: Metasurface optics for extended depth-of-field Spectral deconvolution of multiple contrast agents Speckle modulation for improved diagnostic clarity Noninvasive lymphatic system mapping Scientific Honors : Pew-Stewart Scholar for Cancer Research AFOSR Young Investigator NIH Early Independence Award Forbes 30 Under 30 (x2) Chan Zuckerberg BioHub Investigator His lab team has developed clinical prototypes including OcuBell Inc. 's ophthalmic imaging systems and Visby Medical 's diagnostic platforms. Current research spans from in vivo glycoprotein imaging to de novo biosensor development for real-time disease monitoring in awake animal models.

Sean J. Morrisonمشاهده پروفایل

استاد

• Stem Cell Biology
• Cancer Progression
• Metabolism
• +۳ مورد دیگر

Sean J. Morrison is the founding Director of the Children’s Medical Center Research Institute at UT Southwestern (CRI) and a Howard Hughes Medical Institute Investigator. He holds the Mary McDermott Cook Chair in Pediatric Genetics and the Kathryne and Gene Bishop Distinguished Chair in Pediatric Research. Dr. Morrison earned his B.Sc. in Biology and Chemistry from Dalhousie University (1991), a Ph.D. in Immunology from Stanford University (1996), and completed a postdoctoral fellowship in Neurobiology at Caltech (1999). Education: B.Sc. - Dalhousie University (Biology & Chemistry, 1991) Ph.D. - Stanford University (Immunology, 1996) Postdoctoral Fellowship - Caltech (Neurobiology, 1999) Research Interests: Dr. Morrison’s laboratory investigates the mechanisms that maintain adult tissues and how cancer cells exploit these processes to form tumors. His team compares stem cell and cancer cell replication mechanisms to develop novel regenerative medicine and anticancer therapies. Key areas include: Stem cell self-renewal and aging Metabolic regulation of hematopoietic stem cells Leptin Receptor+ stromal cell function Cancer progression and metastasis Proteostasis and niche biology Mechanotransduction in stem cell niches Publications reveal trends in stem cell metabolism, tumor heterogeneity, and niche dynamics across Science , Nature , and Cell . His work on retrotransposons in stem cell activation (2024) and β-adrenergic receptor inhibition in hematopoietic regeneration (2024) highlights emerging therapeutic targets. Awards & Recognitions: Dr. Morrison is an elected member of the U.S. National Academy of Medicine (2018), National Academy of Sciences (2020), and EMBO (2023). He received the Presidential Early Career Award (2003), MERIT Award from NIA (2009), and UT Southwestern’s Excellence in Postdoctoral Mentoring Award (2020). Mentorship & Leadership: Dozens of graduate students and postdoctoral fellows from his lab have secured academic leadership roles or industry positions. He served as President of the International Society for Stem Cell Research (2015–2016) and actively engages in public policy debates about stem cell research, including Michigan’s constitutional protections for regenerative medicine.

Philip Booneمشاهده پروفایل

دانشگاهی

• Medical Genetics
• Genomics
• Pediatric Genetics
• +۴ مورد دیگر

Philip Boone, MD, PhD, is an Attending Physician in the Division of Genetics and Genomics at Boston Children's Hospital and an Instructor of Pediatrics at Harvard Medical School. He specializes in medical genetics with particular expertise in rare disorders, medical mysteries, deletion and duplication syndromes, and Cornelia de Lange syndrome. Dr. Boone sees patients at Boston Children's Brookline location (2 Brookline Place, 7th Floor) and provides comprehensive genetic care including diagnostics, counseling, and individualized management. Stanford University (Undergraduate, 2006) Baylor College of Medicine (Graduate & Medical School, 2013-2014) Boston Combined Residency Program (Internship & Residency, 2016-2020) Harvard Medical School Genetics Training Program (Fellowship, 2020) Dr. Boone's research focuses on neurodevelopmental disorders, chromatin regulation, and genetic diagnostics. His work spans from fundamental genetic mechanisms to clinical applications, with particular emphasis on cohesinopathies including Cornelia de Lange syndrome. He has contributed significantly to understanding genetic variants associated with growth disorders, developmental features, and structural chromosomal abnormalities. His research combines advanced genomic technologies with clinical insights to improve diagnosis and management of rare genetic conditions. Analysis of Dr. Boone's publication record reveals a strong focus on medical genetics with emphasis on neurodevelopmental disorders, chromatin regulation, and genetic diagnostics. His work spans basic research on gene function and regulation to clinical applications in rare disease diagnosis. A notable trend is his investigation of cohesin complex disorders, particularly SMC3 variants and their relationship to Cornelia de Lange syndrome. His publications demonstrate expertise in both traditional genetic analysis and cutting-edge genomic technologies including long-read sequencing and telomere-to-telomere assembly. Dr. Boone actively contributes to medical education through publications on genetic diagnostics and distance learning resources for medical genetics. He has co-authored educational materials that help advance the field's knowledge base and training capabilities. As an attending physician in the Division of Genetics and Genomics at Boston Children's Hospital and a research fellow in the Center for Genomic Medicine at Massachusetts General Hospital, Dr. Boone works within one of the largest pediatric genetics practices in the country. The division includes over 30 board-certified clinical geneticists, genetic counselors, dieticians, and nursing staff who provide comprehensive care for patients with both common and extremely rare genetic conditions.

Michael Harrisonمشاهده پروفایل

استادیار

• Vascular Biology
• Regenerative Medicine
• Developmental Biology
• +۱۱ مورد دیگر

Michael Harrison is an Assistant Professor in the Department of Cell and Developmental Biology at Weill Cornell Medicine, where he leads the Regeneration and Development Lab within the Graduate School of Medical Sciences. His research focuses on vascular development and regeneration using zebrafish as a model organism, with emphasis on coronary and cerebral vasculature. Education: B.Sc. in Genetics, University of Edinburgh (2005) Ph.D. in Developmental Genetics, University of Sheffield (mentor: Vincent Cunliffe) Postdoctoral Fellowship, Saban Research Institute, Children’s Hospital Los Angeles (CIRM Fellow) Harrison's research centers on understanding how blood and lymphatic vessels form and regenerate, particularly in the heart and brain. His lab investigates coronary vessel development, the role of lymphatic systems in inflammation and regeneration, and revascularization after injury. By leveraging zebrafish genetics and advanced imaging, his work aims to uncover pathways that could be harnessed for regenerative therapies in humans. His recent publications reveal key signaling mechanisms such as Cxcr4-Cxcl12 in coronary development and the two-step formation of cardiac lymphatics. The 15 most recent articles demonstrate a strong, consistent research trajectory in vascular biology and regeneration, with increasing use of advanced techniques like single-nuclei multiomics, fluidic imaging devices, and CRISPR-based genome editing. His work spans developmental mechanisms, functional imaging, and translational applications in cardiac repair. Scientific Awards: No awards explicitly mentioned in the provided text. Harrison actively mentors a team of postdoctoral fellows, research assistants, and students, several of whom have progressed to medical school or research careers. His lab collaborates extensively, particularly with Ching-Ling Lien's group. He has secured research space and funding to support ongoing projects in cardiac and cerebral vasculature. The lab is actively recruiting rotation students from BCMB, PBSB, IMP, and Tri-Institutional programs, as well as postdoctoral researchers and research assistants, indicating an expanding research team and active grant support. Labs and Teams: Regeneration and Development Lab, Weill Cornell Medicine Collaborations with Ching-Ling Lien Lab Member of Tri-Institutional PhD Programs Active participation in BCMB, PBSB, and IMP training programs

Blanka Sharmaمشاهده پروفایل

دانشیار

• Nanomedicine
• Stem Cells
• Biomaterials
• +۳ مورد دیگر

Blanka Sharma, Ph.D., is an Associate Professor in the J. Crayton Pruitt Family Department of Biomedical Engineering at the University of Florida's Herbert Wertheim College of Engineering. Her research focuses on nanomedicine, stem cells, biomaterials, and targeted delivery systems for regenerative medicine and cancer therapy. She holds a B.A.Sc. in Chemical Engineering from the University of Waterloo (1999), a Ph.D. in Biomedical Engineering from Johns Hopkins University (2005), and completed a postdoctoral fellowship at the Cleveland Clinic (2005–2008). Dr. Sharma’s work explores material-cell interactions to develop therapies addressing inflammatory mechanisms in diseases like osteoarthritis and cancer. Notable achievements include pioneering biomaterials for cartilage repair and nanoparticle-based drug delivery systems. She has received prestigious awards, including the NSF CAREER Award (2019) and the UF Pramod P. Khargonekar Junior Faculty Award (2019–2020). Her research spans nanomedicine, tumor microenvironment engineering, and immunotherapy optimization. Recent studies include ROS-scavenging manganese dioxide nanoparticles for osteoarthritis and NK cell mechanosensing in tumors. She leads the Sharma Laboratory, advancing translational research in regenerative medicine and oncology.

Megan Laura McCainمشاهده پروفایل

استاد

• Biomedical Engineering
• Tissue Engineering
• Regenerative Medicine
• +۴ مورد دیگر

Megan Laura McCain is a Professor of Biomedical Engineering at the University of Southern California (USC), with a secondary appointment in the Department of Stem Cell Biology and Regenerative Medicine at the Keck School of Medicine. She leads the McCain Lab, focused on developing microphysiological systems, particularly heart- and muscle-on-a-chip models, to study disease mechanisms and therapeutic responses. McCain holds affiliations with the Biomedical Engineering Society, American Society for Cell Biology, and American Heart Association. Her education includes a B.S. in Biomedical Engineering from Washington University in St. Louis (2006), a Ph.D. in Engineering and Applied Sciences from Harvard University (2012), and postdoctoral research at Harvard’s Wyss Institute. Notable awards include the American Heart Association Pre-doctoral Fellowship and Harvard’s Derek Bok Certificate of Distinction in Teaching. McCain’s research integrates tissue engineering, stem cell biology, and microfluidics to model complex biological systems. Her work emphasizes understanding how microenvironments influence cellular behavior in diseases like cardiovascular disorders and muscular dystrophy. Recent studies explore paracrine interactions in engineered tissues, sex-based proteomic differences in vascular cells, and hypoxia-induced signaling in cardiac fibroblasts. Her scientific contributions include advancements in 3D bioprinting, microfluidic platforms for disease modeling, and synthetic biology tools for cellular control. McCain’s lab collaborates widely to translate findings into clinical applications, such as personalized medicine and regenerative therapies.

Griffin Weberمشاهده پروفایل

دانشیار

• Biomedical Informatics
• Social Network Analysis
• Team Science
• +۵ مورد دیگر

Griffin Weber, M.D., Ph.D., is an Associate Professor of Medicine and Biomedical Informatics at Harvard Medical School (HMS) and Beth Israel Deaconess Medical Center (BIDMC). He directs the Biomedical Research Informatics Core (BRIC) at BIDMC. His research focuses on expertise mining, social network analysis, and biomedical informatics. Key contributions include developing Profiles RNS (an open-source research networking platform) and i2b2 / SHRINE federated query tools for clinical data. He holds MD and PhD degrees from Harvard (2007), and earlier degrees in bioengineering and computer science. Education: SB in Bioengineering (Harvard, 2000), SM/PhD in Computer Science (Harvard, 2004/2005), MD (Harvard, 2007). He served as Harvard Medical School's first Chief Technology Officer, building educational platforms for 500+ courses. His work spans DNA microarrays, breast cancer tumor modeling, and EHR bias analysis. Research Interests: Leveraging informatics to improve healthcare through federated data systems, team science dynamics, and EHR analysis. Projects include Profiles RNS for researcher networks and i2b2 for clinical data queries across institutions. He explores biases in EHR data filtering and visualizing healthcare system dynamics in biomedical data. Grant Leadership: Principal investigator on NIH grants addressing EHR biases (R01LM013345), healthcare system dynamics (U01CA198934), and scientific workforce networks (U01GM112623). Collaborator on PCORI and NIH-funded initiatives. Awards: 2020 Fellow of the American College of Medical Informatics; 2011 Top Podium Presentation (AMIA); 2007 Medical Technology Award (Massachusetts Medical Society). Labs/Teams: Leads BRIC at BIDMC, collaborates on i2b2/SHRINE, and contributes to the 4CE consortium for federated healthcare data analysis.

• Pharmacokinetics
• Pharmacometrics
• Population pharmacokinetics
• +۵ مورد دیگر

Markus Hovd is a Senior Lecturer at the Section for Pharmacology and Pharmaceutical Biosciences within the Department of Pharmacy at the University of Oslo's Faculty of Mathematics and Natural Sciences. He also maintains an affiliation with the Neurosurgical Department. His work focuses on pharmacokinetic research with applications in clinical practice and personalized medicine. Philosophiae Doctor (PhD), Department of Pharmacy, University of Oslo, 2024 Master of Pharmacy, Department of Pharmacy, University of Oslo, 2019 Hovd's primary research interest centers on the mechanisms behind pharmacokinetic inter-individual variability and the development of models to aid in personalization of medicine. His research methodology includes population- and physiology-based pharmacokinetic models, in vitro-in vivo extrapolation, and clinical trials. His work spans multiple therapeutic areas including kidney transplantation, obesity-related pharmacokinetics, and cerebrospinal fluid dynamics. Analysis of Hovd's publications reveals a strong focus on pharmacokinetic applications in specialized patient populations, particularly kidney transplant recipients and patients who have undergone bariatric surgery. His research demonstrates expertise in population pharmacokinetic modeling, drug transport mechanisms, and the impact of physiological changes on drug disposition. A significant portion of his work addresses the challenges of drug dosing in complex clinical scenarios where standard pharmacokinetic assumptions may not apply. Hovd serves as a representative for temporary teaching staff on both the Teaching Committee and the Department Board at the Department of Pharmacy. His teaching portfolio includes courses in Pharmaceutical Biochemistry, Pharmacotherapy, Pharmaceutical Microbiology, Research Preparation in Biology, and Applied Pharmacokinetics and Dosing in Clinical Practice. Hovd is actively involved in multiple research groups including Pharmacokinetics, Kidney Transplant Medicine, and the KG Jebsen Center for Cerebrospinal Fluid Research, where he contributes his pharmacokinetic expertise to interdisciplinary neuroscience research.

Kathleen M. Caronمشاهده پروفایل

استاد

• Cell Biology
• Physiology
• Lymphatic System
• +۵ مورد دیگر

Kathleen M. Caron is a Professor and Chair of the Department of Cell Biology and Physiology at the University of North Carolina (UNC) School of Medicine. Her research focuses on G protein-coupled receptor (GPCR) pathways, particularly adrenomedullin (AM) and calcitonin gene-related peptide (CGRP) signaling, in lymphatic vascular development and gastrointestinal biology. University: University of North Carolina at Chapel Hill School: UNC School of Medicine Department: Department of Cell Biology and Physiology Research Interests: Dr. Caron's work investigates GPCR systems in lymphatic endothelial cell function, lymphangiogenesis, and neurovascular-gastrointestinal crosstalk. Key areas include: AM-CLR-RAMP2 signaling in developmental lymphangiogenesis CGRP's role in lacteal permeability and lipid absorption Lymphatic-epithelial interactions in gastrointestinal disease Pharmacological targeting of GPCRs for vascular and metabolic disorders VE-cadherin interactome in cardiac lymphatic maintenance Neuroinflammatory mechanisms in migraine pathophysiology Scientific Contributions: Her lab discovered the first pharmacologically-tractable GPCR system (AM-CLR) in lymphatic development and identified its role in human hydrops fetalis mutations. Recent studies explore CGRP signaling in meningeal lymphatics and metabolic dysregulation in lacteal-null models. Affiliations: Member of the UNC Center for Gastrointestinal Biology and Disease (CGIBD) and contributor to interdisciplinary research at UNC.

Kari Alitaloمشاهده پروفایل

استاد

• Cancer Biology
• Angiogenesis
• Lymphangiogenesis
• +۵ مورد دیگر

Kari Alitalo is an Academy Professor and Research Director at HUS Radiology and Pathology, University of Helsinki. He serves as a Supervisor in the Doctoral Programme in Integrative Life Science and the Doctoral Programme in Biomedicine. Alitalo directs the CAN-PRO - Translational Cancer Medicine Program and has led the Cancer Biology Research Programme at the University of Helsinki since 1999. His research primarily focuses on blood and lymphatic vessel growth factors with applications in cancer treatment and cardiovascular diseases. Alitalo's work spans angiogenesis, lymphangiogenesis, molecular biology, and translational medicine. His research group has made significant contributions to understanding vascular endothelial growth factors and their therapeutic applications. Alitalo's publication record shows consistent productivity with approximately 670 research outputs. His recent work (2023-2025) demonstrates continued focus on lymphatic system biology, vascular growth factors, and their therapeutic applications in cancer and cardiovascular diseases. The publications reveal a strong emphasis on molecular mechanisms of lymphangiogenesis, tumor angiogenesis, and potential therapeutic interventions. A.I. Virtanen Prize (2013) Biomedicum Helsinki lecture and Medal (2010) Eric K Fernström Foundation's Nordic Prize (2005) Finnish Science Prize (2013) Louis-Jeantet Prize For Medicine (2006) Professor Alitalo has supervised numerous doctoral students, with 52 dissertation supervisor or co-supervisor activities documented. He currently leads multiple active research projects including Cancer Foundation 2025/Alitalo, Biocenter Finland FIRI2023, and Juselius 2023-2026. His research group continues to explore vascular biology with significant implications for cancer treatment and cardiovascular medicine.

Kerry Empeyمشاهده پروفایل

دانشیار

• Vaccine Development
• Immunology
• Clinical Translational Science
• +۵ مورد دیگر

Kerry Empey is an Associate Professor in the Department of Pharmacy and Therapeutics at the University of Pittsburgh School of Pharmacy. She serves as the Associate Dean of Graduate & Postdoctoral Programs and holds secondary appointments in the Department of Immunology, Center for Vaccine Research, and Clinical and Translational Science Institute (CTSI) in the School of Medicine. Her research focuses on optimizing vaccines and therapies for vulnerable populations, particularly infants and pregnant women, targeting respiratory syncytial virus (RSV) and other pulmonary pathogens. She directs the Certificate in Clinical Translational Science for health sciences graduate students. Education: PharmD from University of Rhode Island; PhD in Clinical Pharmaceutical Sciences from University of Kentucky; completed PGY1/PGY2 residencies in Pharmacy Practice and Infectious Diseases at University of Kentucky. Research Interests: Immune response modulation, vaccine adjuvant development, age-dependent immunity, pharmacokinetics/pharmacodynamics of monoclonal antibodies, and translational research in pediatric and maternal immunization strategies. Her work emphasizes vaccine safety and efficacy in infants, maternal immunization's protective effects, and understanding cytokine-mediated viral clearance mechanisms. Recent publications highlight advancements in RSV vaccine formulations, maternal immunization strategies, and immune mechanisms driving post-viral bacterial infections. Collaborative studies with vaccine experts and nanotechnology teams explore novel delivery systems for optimal immune responses.

David L. Mattsonمشاهده پروفایل

استاد

• Hypertension
• Renal Physiology
• Salt-Sensitive Hypertension
• +۷ مورد دیگر

David L. Mattson is Professor and Department Chair in the Department of Physiology at the Medical College of Georgia, Augusta University . He is also the Georgia Research Alliance (GRA) Eminent Scholar in Hypertension, reflecting his national leadership in cardiovascular and renal research. His career spans decades of impactful work in hypertension, renal physiology, and immune system interactions. Dr. Mattson earned his BS in Biology from the University of Minnesota Duluth (1984) and his PhD in Physiological Psychology from the Medical College of Wisconsin (1990). He served on the faculty at the Medical College of Wisconsin from 1992 to 2019, achieving tenure and leadership roles including Interim Senior Associate Dean of Research. He joined Augusta University in 2019 as Department Chair. His research focuses on the genetic, immunological, and physiological mechanisms of salt-sensitive hypertension and kidney damage . A major emphasis is on the role of T cells, oxidative stress (particularly NOX2), and epigenetic regulation (e.g., DNA methylation) in hypertension. His lab uses integrative physiology, molecular biology, and genetically modified animal models, especially the Dahl salt-sensitive rat. His work has revealed critical insights into how immune cells infiltrate the kidney and exacerbate hypertension. His recent publications (2022–2025) span topics including T cell immunometabolism, NOX2 signaling, dietary protein effects, epigenetic regulation, and renal perfusion dynamics . These studies appear in top journals such as Hypertension , American Journal of Physiology , and Nature Reviews Nephrology , demonstrating a consistent trend toward immune-renal interactions and precision mechanisms in hypertension. Dr. Mattson has received numerous honors, including: Starling Award, American Physiological Society (2018) Faculty Service Award, Medical College of Wisconsin (2018) Established Investigator Award, American Heart Association (2000) Multiple teaching and service awards He is deeply involved in academic service, including editorial board roles ( Hypertension , Physiological Genomics ), grant review, and professional society leadership. He mentors graduate students and postdoctoral fellows, with lab members including instructors and PhD candidates. He leads the Kidney and Hypertension Research Group and holds significant research funding, including NIH grants such as P01HL134604. His laboratory is a hub of interdisciplinary research, integrating physiology, immunology, and genomics to uncover novel therapeutic targets for hypertension and kidney disease. Future work continues to explore immune cell contributions, sex differences, and environmental modulators of disease.

Rodney J. Taylorمشاهده پروفایل

استاد

• Head and Neck Surgical Oncology
• Rhinology and Sinus Disease
• Endocrine Surgery
• +۷ مورد دیگر

Rodney J. Taylor is a Professor and Chair of the Department of Otorhinolaryngology-Head & Neck Surgery at the University of Maryland School of Medicine. With clinical expertise in head and neck cancer management, skull base surgery, and endocrine surgery, he has led national-recognized research initiatives since joining the faculty in 2001. As Chief of Otolaryngology at the Baltimore Veteran’s Administration Medical Center, he combines clinical excellence with scientific innovation. Education : MD from Harvard Medical School (1995), MPH from University of Michigan School of Public Health (1999) Training : Residency in Otolaryngology-Head & Neck Surgery at University of Michigan (1995-2001) Dr. Taylor's research focuses on improving head and neck cancer survival through immune-cytotoxicity studies, SCCHN cell line analysis, xenograft models, and clinical trials. His collaborations with Dr. Zalzman's lab explore cancer stem cell immortality mechanisms and regenerative medicine advancements. Current research also investigates NK cell FcγRIIIa polymorphisms for personalized antibody therapy. Scientific achievements include developing the Neck Dissection Impairment Index and recognition as a top otolaryngologist. His lab secures funding from NIH, DOD, and philanthropic sources like the Orokawa Foundation and Weitzman family. Research trends emphasize translational oncology, immunotherapy, and stem cell applications in head and neck diseases. Scientific Awards : Ranked among 'America’s Top Otolaryngologists'